Quotient’s Cardiff radiolabelling unit operational

Related tags Pharmacology

Drug discovery services firm Quotient Bioresearch says its new radiochemistry facility in Cardiff, Wales is fully operational.

The facility, plans for which were unveiled in January​, will produce radiolabelled compounds, including 14-C, for Quotient’s roster of pharmaceutical, biopharmaceutical and medical device developer clients.

The unit was established to act as a hub for Quotient’s labelling business, which was formed through the acquisition of Amersham Radio-labelling from US giant GE Healthcare in mid 2009.

Quotient, which claims the unit houses the “the largest and most experienced team of radiosynthesis chemists in the world,” ​expects to provide labelled materials for more than 250 customers worldwide.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers

Follow us

Products

View more

Webinars